Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Therapeutic drug monitoring of nevirapine in resource-limited settings
Clinical Infectious Diseases, Volume 47, No. 10, Year 2008
Notification
URL copied to clipboard!
Description
Background. We developed a simple and inexpensive thin-layer chromatography (TLC) assay for semiquantitative detection of saliva concentrations of nevirapine in resource-limited settings. The method was validated in an African target population. Methods. Paired plasma and saliva nevirapine concentrations were assayed by high-performance liquid chromatography (HPLC); saliva concentrations of nevirapine were also assayed by TLC. The rate of false-positive results was the proportion of subtherapeutic nevirapine saliva and plasma concentrations determined by HPLC that were judged to be therapeutic in saliva specimens by TLC. The rate of false-negative results was the proportion of therapeutic nevirapine saliva and plasma concentrations determined by HPLC that were judged to be subtherapeutic in saliva specimens by TLC. The extent of agreement in TLC readings between 5 technicians and 2 batches of TLC sheets was evaluated. Results. Twenty-five (9%) of 286 African adults had a subtherapeutic plasma nevirapine concentration. The median ratio of nevirapine concentrations in saliva to those in plasma was 0.51:1. The rate of false-positive results for TLC was 0% (0 of 23 specimens) when TLC results were compared with HPLC results for saliva specimens and 8% (2 of 25 specimens) when TLC results were compared with HPLC results for plasma specimens. The rate of false-negative results for TLC was 1% (3 of 263 specimens) when TLC results were compared with HPLC results for saliva specimens and 1% (3 of 261 specimens) when TLC results were compared with HPLC results for plasma specimens. The extent of agreement of TLC results was substantial for the 5 technicians (Fleiss's κ = 0.77) and for the 2 batches of sheets (Cohen's p0.80). Conclusions. The TLC assay was found to be sensitive, specific, and robust in the detection of subtherapeutic nevirapine concentrations in saliva specimens obtained from African HIV-infected adults. It is an attractive alternative to HPLC for therapeutic drug monitoring of nevirapine in resource-limited settings. © 2008 by the Infectious Diseases Society of America. All rights reserved.
Authors & Co-Authors
L'Homme, Rafaëlla
Netherlands, Nijmegen
Radboud University Medical Center
Muro, Eva Prosper
Tanzania, Moshi
Kilimanjaro Christian Medical Centre
Droste, Jacqueline A.H.
Netherlands, Nijmegen
Radboud University Medical Center
Wolters, Liselotte R.
Tanzania, Moshi
Kilimanjaro Christian Medical Centre
Van Ewijk-Beneken Kolmer, Noor W.J.
Netherlands, Nijmegen
Radboud University Medical Center
Schimana, Werner
Tanzania, Moshi
Kilimanjaro Christian Medical Centre
Burger, David M.
Netherlands, Nijmegen
Radboud University Medical Center
Statistics
Citations: 18
Authors: 7
Affiliations: 2
Identifiers
Doi:
10.1086/592694
ISSN:
10584838
Research Areas
Infectious Diseases
Study Design
Cross Sectional Study